Investigation of the Effects of CGF and A-PRF on Pain, Edema and Trismus After Impacted Lower Third Molar Surgery

Dr. Damla Torul75 enrolled

Overview

The objective of this case-control intervention study is to explore the effectiveness of Concentrated Growth Factor (CGF) and Advanced Platelet Rich Fibrin (A-PRF) on Pain, Edema and Trismus After Impacted Lower Third Molar Surgery

In the present study, 75 patient, whose ages ranged between 18-30 and have an impacted lower third molar which is in vertical or mesiyoangular position and has class I and II ramus relationship and class B and C depth, will included. 75 patient will divided randomly into three groups as CGF, A-PRF and Control. After third molar surgery CGF and A-PRF will prepared and applied to the extraction sockets in CGF and A-PRF groups. nothing will applied to the control group. Post operative pain, edema and trismus will measured at 2nd and 7th days.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Trismus Edema Pain Post-Op Complication

Interventions

Concentrated Growth Factor (CGF)OTHER

CGF application (9 ml venous blood will harvested from the participants in the CGF group and centrifuged according to the protocol for CGF)

Advanced Platelet Rich Fibrin (A-PRF)OTHER

A-PRF application (9 ml venous blood will harvested from the participants in the CGF group and centrifuged according to the protocol for A-PRF)

ControlOTHER

Nothing applied after extraction

Eligibility

Sex: ALLMin age: 18 YearsMax age: 30 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Patients presenting asymptomatic impacted lower third molar tooth in the vertical or mesioanguler position according to the Winter classification, Class I and II ramus relation and class B and C depth according to Pell-Gregory classification * Patients between the ages of 18-30, * Non-smokers, * Patients with ASA I status Exclusion Criteria: * Who does not want to be volunteer for the study, * Do not comply with post-operative recommendations, * Operation lasting more than 30 minutes, * During pregnancy or lactation, * Have a chronic systemic disorder that may affect healing. * Unable to cooperate, * Post-operative infection, * Patients with pericoronitis

Locations (1)

Ordu University

Ordu, Turkey (Türkiye)

Outcomes

Primary Outcomes

Edema-amount change of swelling

In order to evaluate the amount change of swelling after the operation, horizontal and vertical measurements will be made from 5 reference points including tragus, lip corner, soft tissue pogonion, lateral cantus of the eye and gonion. The first measurement between the tragus-lip corner, the second measurement will be obtained by measuring the horizontal distance between the tragus-soft tissue pogonion. The third measurement will be determined by the measurement of the vertical distance between the outer corner of the eye and the gonion. to determine the change in the swelling measurements performed before surgery and at 2nd-7th days after surgery.

Time frame: Baseline, 2nd and 7th days

Secondary Outcomes

Trismus- degree of change (limitation) in maximum mouth opening

The maximum mouth opening will be determined as the distance between the right lower and upper right central.

Time frame: Baseline, 2nd and 7th days

Post operative Pain: visual analog (VAS) scale

For the evaluation of the pain, the visual analog scale (VAS) will be used to express the absence of pain in the initial part on a straight line (0) and the end part to express the unbearable pain (10). 0 (no pain)--------------------------------------------------------------------------------10 (unbearable pain) Higher values of the scale represent worse outcome.

Time frame: 6th and 24th hours, 2nd and 7th days

Post-operative symptom severity (PoSSe) scale

The evaluation of the change in postoperative quality of life will be done with a scale of post-operative symptom severity (PoSSe) consisting of 15-item questionnaire in which the effect of operation on eating, speech, sensation, appearance, pain, disease and daily activities is evaluated. This questionnaire was divided into subscales corresponding to seven main adverse effects, andfor each possible answer there was a score ranging from 0 to a variable number. For total possible answer there was a score ranging from 0 to a 97.9. Higher values of the scale represent worse outcome.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.